The regulatory mechanism and potential application of IL-23 in autoimmune diseases
IL-23 is a heterodimeric pro-inflammatory cytokine secreted by dendritic cells and macrophages that belongs to the IL-12 family. It has pro-inflammatory effects and is a key cytokine and upstream regulatory cytokine involved in protective immune responses, stimulating the differentiation and prolife...
Main Authors: | De-Kai Xiong, Xiang Shi, Miao-Miao Han, Xing-Min Zhang, Na-Na Wu, Xiu-Yue Sheng, Ji-Nian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.982238/full |
Similar Items
-
Increased IL-23R+ Th Cells Population Exhibits Higher SLEDAI-2K Scores in Systemic Lupus Erythematosus Patients
by: Aziz Farah Izati, et al.
Published: (2021-08-01) -
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
by: Taoming Liu, et al.
Published: (2020-11-01) -
No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors
by: Hua Zhang, et al.
Published: (2022-02-01) -
Targeting IL-23 in psoriasis: current perspectives
by: Fotiadou C, et al.
Published: (2018-01-01) -
Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
by: Hélène Bugaut, et al.
Published: (2021-02-01)